| 1 |
Nogueira RG, Jovin TG, Liu X, et al. Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data Meta-analysis [J]. Lancet, 2025, 405(10472): 61-69.
|
| 2 |
Liu X, Dai Q, Ye R, et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial [J]. Lancet Neurol, 2020, 19(2): 115-122.
|
| 3 |
Langezaal LC, Van Der Hoeven EJ, Mont’alverne FJ, et al. Endovascular therapy for stroke due to basilar-artery occlusion [J]. New Engl J Med, 2021, 384(20): 1910-1920.
|
| 4 |
Tao C, Nogueira RG, Zhu Y, et al. Trial of endovascular treatment of acute basilar-artery occlusion [J]. New Engl J Med, 2022, 387(15): 1361-1372.
|
| 5 |
Jovin TG, Li C, Wu L, et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion [J]. New Engl J Med, 2022, 387(15): 1373-1384.
|
| 6 |
Psychogios M, Brehm A, Ribo M, et al. Endovascular treatment for stroke due to occlusion of medium or distal vessels [J]. New Engl J Med, 2025, 392(14): 1374-1384.
|
| 7 |
Goyal M, Ospel JM, Ganesh A, et al. Endovascular treatment of stroke due to medium-vessel occlusion [J]. New Engl J Med, 2025, 392(14): 1385-1395.
|
| 8 |
Liu C, Guo CW, Li FL, et al. Intra-arterial Urokinase after endovascular reperfusion for acute ischemic stroke [J]. JAMA, 2025, 333(7): 589-598.
|
| 9 |
Huang J, Yang J, Liu C, et al; POST-TNK Investigators. Intra-arterial Tenecteplase following endovascular reperfusion for large vessel occlusion acute ischemic stroke: the POST-TNK randomized clinical trial [J]. JAMA, 2025, 333(7): 579-588.
|
| 10 |
Hu W, Tao CR, Wang L, et al. Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial [J]. BMJ, 2025, 388: e080489.
|
| 11 |
Miao Z, Luo G, Song L, et al; ANGEL-TNK Investigators. Intra-arterial Tenecteplase for acute stroke after successful endovascular therapy: the ANGEL-TNK randomized clinical trial [J]. JAMA, 2025, 334(7): 582-591.
|
| 12 |
Yang XG, He XJ, Xu YT, et al. Intra-arterial Alteplase after successful endovascular reperfusion in acute stroke [J]. JAMA, 2025, 334(19): 1728-1739.
|
| 13 |
Cottarelli A, Mamoon R, Ji R, et al. Low hemoglobin causes hematoma expansion and poor intracerebral hemorrhage outcomes [J]. Stroke, 2025, 56(5): 1234-1242.
|
| 14 |
Polymeris AA, Lang MF, Hakim A, et al. Effect of decompressive craniectomy according to location of deep intracerebral hemorrhage: a SWITCH trial analysis [J]. Stroke, 2026, 57(1): 12-19.
|
| 15 |
Yassi N, Zhao H, Churilov L, et al. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial [J]. Lancet Neurol, 2024, 23(6): 577-587.
|
| 16 |
Naidech AM, Jovanovic B, Wartenberg KE, et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage [J]. Crit Care Med, 2007, 35(10): 2383-2389.
|
| 17 |
English SW, Delaney A, Fergusson DA, et al; SAHARA Trial Investigators on behalf of the Canadian Critical Care Trials Group; Canadian Critical Care Trials Group. Liberal or restrictive transfusion strategy in aneurysmal subarachnoid hemorrhage [J]. N Engl J Med, 2025, 392(11): 1079-1088.
|
| 18 |
Taleb C, Gouvea Bogossian E, Bittencour Rynkowski C, et al. Liberal versus restrictive transfusion strategies in subarachnoid hemorrhage: a secondary analysis of the TRAIN study [J]. Crit Care, 2025, 29(1): 67.
|
| 19 |
Larcipretti ALL, Udoma-Udofa OC, Gomes FC, et al. Transfusion practices in traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials [J]. Crit Care Med, 2025, 53(4): e963-e972.
|
| 20 |
Atkin-Jones T, Solorzano-Aldana MC, Rezk A, et al. Impact of oxygen and carbon dioxide levels on mortality in moderate to severe traumatic brain injury: a systematic review and meta-analysis [J]. Crit Care, 2025, 29(1): 357.
|
| 21 |
Taran S, Citerio G, Taccone FS, et al. Dynamic driving pressure and clinical outcomes in mechanically ventilated patients with acute brain injury: a secondary analysis of the VENTIBRAIN study [J]. Intensive Care Med, 2026, 52(1): 31-41.
|
| 22 |
Brasil S, Patriota GC, Godoy DA, et al. Monro-Kellie 4.0: moving from intracranial pressure to intracranial dynamics [J]. Crit Care, 2025, 29(1): 229.
|
| 23 |
Robba C, Picetti E, Vásquez-García S, et al. The Brussels consensus for non-invasive ICP monitoring when invasive systems are not available in the care of TBI patients (the B-ICONIC consensus, recommendations, and management algorithm) [J]. Intensive Care Med, 2025, 51(1): 4-20.
|
| 24 |
Manley GT, Dams-O'Connor K, Alosco ML, et al; NIH-NINDS TBI Classification and Nomenclature Initiative. A new characterisation of acute traumatic brain injury: the NIH-NINDS TBI Classification and Nomenclature Initiative [J]. Lancet Neurol, 2025, 24(6): 512-523.
|
| 25 |
Lisi I, Moro F, Mazzone E, et al. Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injury [J]. Brain, 2025, 148(4): 1062-1080.
|
| 26 |
Sonneville R, Azabou E, Bailly P, et al. Management of severe acute encephalopathy in the ICU: an expert consensus statement from the French Society of Intensive Care Medicine [J]. Ann Intensive Care, 2025, 15(1): 37.
|
| 27 |
Bodien YG, Busl KM, Chang CWJ, et al. Disorders of consciousness diagnosis, interventions, and prognostication for the intensivist: report of the 2025 ISICEM roundtable [J]. Intensive Care Med, 2026, 52(1): 42-62.
|